To evaluate the otoprotective efficacy of the compounds, cochlear samples are immunostained with a combination of markers specific for hair cells (Myosin V1, Myosin VIIA, Parvalbumin, etc.), SGNs (TUJ1, Neurofilament, etc.), f-actin, cell death, cell stress, etc
For a 10 mg vial targeting 100 mcg per 0.1 mL spray, you need a concentration of 1,000 mcg/mL, so you add 10 mL of bacteriostatic water
10.1007/s10803-020-04458-8 J
Lipid droplet-derived monounsaturated fatty acids traffic via PLIN5 to allosterically activate SIRT1
72 For treatment of genotype 4, the SYNERGY trial demonstrated an SVR rate of 95% by intention to treat analysis following 12 weeks of ledipasvir/sofosbuvir therapy
Caffeine after 2 PM compounds with BPC-157's mild stimulatory effect